ArticleRheumatology and therapy2022

Ustekinumab Is Rapid-Acting and Is an Effective Long-Term Treatment for Patients with Active Psoriatic Arthritis: Real-World Evidence from the Non-interventional SUSTAIN Study.

Jörg Wendler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.